Keutzer Timothy
- SEC CIK
- 0001798155
Latest role at each company
- SPRO Spero Therapeutics, Inc.Chief Operating Officeras of Feb 9, 2026
Trades
Every Form 4 that lists Keutzer Timothy as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| SPROSpero Therapeutics, Inc. | Feb 9, 2026 | Feb 6, 2026 | Keutzer TimothyChief Operating Officer | SSaleCommon Stock | −18.65K | $2.36 | −$44.02K | 742.51K | −2.5% | SEC |
| SPROSpero Therapeutics, Inc. | Feb 5, 2026 | Feb 2 – Feb 4, 2026 | Keutzer TimothyChief Operating Officer | SSaleCommon Stock | −46.59K | $2.1718 | −$101.17K | 761.16K | −5.8% | SEC |
| SPROSpero Therapeutics, Inc. | Sep 3, 2025 | Aug 28, 2025 | Keutzer TimothyChief Operating Officer | SSaleCommon Stock | −1.7K | $1.97 | −$3.34K | 739.74K | −0.2% | SEC |
| SPROSpero Therapeutics, Inc. | Feb 5, 2025 | Feb 5, 2025 | Keutzer TimothyChief Operating Officer | SSaleCommon Stock | −56.54K | $0.78 | −$44.1K | 741.44K | −7.1% | SEC |
| SPROSpero Therapeutics, Inc. | Aug 29, 2024 | Aug 27, 2024 | Keutzer TimothyChief Operating Officer | SSaleCommon Stock | −2.21K | $1.35 | −$2.99K | 531.84K | −0.4% | SEC |
| SPROSpero Therapeutics, Inc. | Feb 5, 2024 | Feb 2, 2024 | Keutzer TimothyChief Operating Officer | SSaleCommon Stock | −30.97K | $1.36 | −$42.12K | 534.05K | −5.5% | SEC |
| SPROSpero Therapeutics, Inc. | Aug 30, 2023 | Aug 28, 2023 | Keutzer TimothyChief Development Officer | SSaleCommon Stock | −1.85K | $1.26 | −$2.34K | 325.29K | −0.6% | SEC |
| SPROSpero Therapeutics, Inc. | Feb 3, 2023 | Feb 2, 2023 | Keutzer TimothyChief Operating Officer | SSaleCommon Stock | −3.39K | $1.86 | −$6.31K | 327.14K | −1.0% | SEC |